Tralokinumab Maintenance Dose Effective in Some Patients With AD Tralokinumab Maintenance Dose Effective in Some Patients With AD

A step-down in tralokinumab dosing to every 4 weeks may be an option for some patients achieving clear or almost clear skin after an initial dosing schedule of every 2 weeks, the investigator said.Medscape Medical News

Source: Medscape Medical News Headlines - June 21, 2021 Category: Consumer Health News Tags: Dermatology News Source Type: news